A juvenile case of MELAS with T3271C mitochondrial DNA mutation

Laura Stenqvist1, Anders Paetau, Leena Valanne

  • 1Department of Neurology, Biomedicum Helsinki, Helsinki University, FIN-00290 Helsinki, Finland. laura.stenqvist@hus.fi

Pediatric Research
|July 12, 2005
PubMed

Insights

This study details a patient with mitochondrial disease caused by a T3271C mutation in mitochondrial DNA. Despite a high mutation load, symptoms were mild in childhood, progressing rapidly later in life.

Area of Science:

  • Genetics
  • Neurology
  • Mitochondrial Biology

Background:

  • Mitochondrial diseases are a group of inherited metabolic disorders.
  • Mitochondrial DNA (mtDNA) mutations can lead to a range of clinical manifestations.
  • Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a severe mitochondrial disorder.

Observation:

  • A patient presented with muscle fatigue and poor growth from age 6.
  • Muscle biopsy showed ragged red fibers and a defect in respiratory enzymes.
  • The patient developed severe neurological symptoms, including epilepsia partialis continua and stroke-like episodes, before death at age 18.

Findings:

  • Genetic analysis revealed a heteroplasmic T3271C mutation in mtDNA with a high mutation load (78-94%).
  • This is the ninth non-Japanese patient reported with this specific mutation.
  • The T3271C mutation, despite high mutant mtDNA proportion, can present with mild childhood symptoms and a rapid terminal phase.

Implications:

  • This case expands the understanding of the phenotypic variability associated with the T3271C mtDNA mutation.
  • It highlights the importance of genetic testing in diagnosing complex mitochondrial disorders.
  • The findings suggest that high mutant mtDNA loads do not always correlate with early-onset severe disease, challenging previous assumptions.